BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 17088913)

  • 1. Underexpression of mineralocorticoid receptor in colorectal carcinomas and association with VEGFR-2 overexpression.
    Di Fabio F; Alvarado C; Majdan A; Gologan A; Voda L; Mitmaker E; Beitel LK; Gordon PH; Trifiro M
    J Gastrointest Surg; 2007 Nov; 11(11):1521-8. PubMed ID: 17703341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma.
    Matušan-Ilijaš K; Damante G; Fabbro D; Dorđević G; Hadžisejdić I; Grahovac M; Avirović M; Grahovac B; Jonjić N; Lučin K
    Clin Transl Oncol; 2013 Jan; 15(1):65-71. PubMed ID: 22855173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.
    Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Int J Colorectal Dis; 2013 Jan; 28(1):9-18. PubMed ID: 22733437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status.
    Rego RL; Foster NR; Smyrk TC; Le M; O'Connell MJ; Sargent DJ; Windschitl H; Sinicrope FA
    Br J Cancer; 2010 Jan; 102(1):165-72. PubMed ID: 19997103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of cancer cells is maintained by EGFR independent of its kinase activity.
    Weihua Z; Tsan R; Huang WC; Wu Q; Chiu CH; Fidler IJ; Hung MC
    Cancer Cell; 2008 May; 13(5):385-93. PubMed ID: 18455122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET detection of epidermal growth factor receptor in colorectal cancer: a real predictor of response to cetuximab treatment?
    Pantaleo MA; Fanti S; Lollini PL; Boschi S; Biasco G
    Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1510-1. PubMed ID: 17447062
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing epidermal growth factor receptor expression in tumours: what is the value of current test methods?
    Dei Tos AP; Ellis I
    Eur J Cancer; 2005 Jul; 41(10):1383-92. PubMed ID: 15919198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determination of epidermal growth factor receptor in normal and neoplastic colorectal mucosa.
    Piazzi G; Paterini P; Ceccarelli C; Pantaleo MA; Biasco G
    Br J Cancer; 2006 Dec; 95(11):1525-8. PubMed ID: 17088913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular detection of epidermal growth factor receptor in colorectal cancer: does it still make sense?
    Nannini M; Pantaleo MA; Paterini P; Piazzi G; Ceccarelli C; La Rovere S; Maleddu A; Biasco G
    Colorectal Dis; 2011 May; 13(5):542-8. PubMed ID: 20070321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases.
    Kuramochi H; Hayashi K; Nakajima G; Kamikozuru H; Yamamoto M; Danenberg KD; Danenberg PV
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):825-31. PubMed ID: 19701635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor.
    Goetz M; Ziebart A; Foersch S; Vieth M; Waldner MJ; Delaney P; Galle PR; Neurath MF; Kiesslich R
    Gastroenterology; 2010 Feb; 138(2):435-46. PubMed ID: 19852961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options.
    Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Pierantoni C; Cascinu S
    Br J Cancer; 2007 Jul; 97(1):92-7. PubMed ID: 17579627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
    Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
    Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy in colorectal cancer: do we know enough?
    Pantaleo MA; Palassini E; Labianca R; Biasco G
    Dig Liver Dis; 2006 Feb; 38(2):71-7. PubMed ID: 16289975
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.